News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Generic Drugmaker Akorn (AKN) Surges On Reports Fresenius SE Is Interested



4/10/2017 7:21:53 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Fresenius SE, Europe’s biggest publicly traded health-care provider, said Friday that it’s in talks to buy U.S. generic drugmaker Akorn Inc.

While discussions are under way, there’s no certainty of a deal, said Fresenius, a maker of dialysis and medical products. The Bad Homburg, Germany-based company didn’t elaborate in a statement about the talks. A spokeswoman for Akorn declined to comment.


Read at Bloomberg
Read at Reuters
Read at Market Watch
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES